Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: Does it have a prognostic significance?

Hematological Oncology

Volumn 28, Issue 4, 2010, Pages 180-184

  Sucak, G ^a   Suyani, E ^a   Ozkurt Z N ^a   Yegin Z A ^a   Aki, Z ^a   Yagci, M ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Abnormal protein band; Haematopoietic stem cell transplantation; Monoclonal gammopathy; Multiple myeloma; Oligoclonal gammopathy

Indexed keywords

OLIGOCLONAL BAND;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650047232     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.936     Document Type: Article

References (13)

1. Caers J, Vande broek I, De Raeve H, et al. Multiple myeloma-an update on diagnosis and treatment. Eur J Haematol 2008; 81: 329-343.
2. Zent CS, Wilson CS, Tricot G, et al. Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood 1998; 91: 3518-3523.
3. Hovenga S, De Wolf J, Guikema JEJ, et al. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation. Bone Marrow Transplant 2000; 25: 723-728.
4. Mark T, Jayabalan D, Coleman M, et al. Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma. Br J Haematol 2008; 143: 654-660.
5. Gerritsen EJ, van Tol MJ, Lankester AC, et al. Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 1993; 82: 3493-3502.
6. Mitus AJ, Stein R, Rappeport JM, et al. Monoclonal and oligoclonal gammopathy after bone marrow transplantation. Blood 1989; 74: 2764-2768.
7. Fischer AM, Simon F, Le Deist F, Blanche S, Griscelli C, Fischer A. Prospective study of the occurrence of monoclonal gammapathies following bone marrow transplantation in young children. Transplantation 1990; 49: 731-735.
8. Gerritsen EJ, Van Tol MJ, Van't Veer MB, et al. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. Blood 1994; 84: 4374-4382.
9. van den Akker TW, Benner R, Radl J. Transient monoclonal gammapathies with lambda light chains. Transplantation 1987; 44: 725-726.
10. Durie BG, Harousseau JL, Miguel JS, et al. International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia 2006; 20: 1467-1473.
11. Hammerström L, Smith CI. Frequent occurence of monoclonal gammopathies with an imbalanced light chain ratio following bone marrow transplantation. Transplantation 1987; 43: 447-449.
12. Maisnar V, Tichỳ M, Smolej L, et al. Isotype class switching after transplantation in multiple myeloma. Neoplasma 2007; 54: 225-228.
13. Wood KL, Twigg HL 3rd, Doseff AI. Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci 2009; 14: 3771-3781.